APT Medical’s Post

New England HIMSS Premier Sponsor Radial Presents: "AI-supported Early Mobilization of Inpatients: A New Approach to Centralizing the Right Care at Home" From 12-1pm EST on Tuesday, December 10th, Anant Vasudevan, MD, MBA, Chief Medical Officer at Radial, will lead this virtual session along with Christopher Wellins, MD, MS, FACP, Senior Medical Director Utilization Management at Maine Medical Center. Our speakers will review the literature supporting the benefits of home-based post-acute care and the impact of early mobilization, plus discuss the partnership between Radial and Maine Medical Center. The discussion will explore how AI tools identify patients appropriate for early mobilization, and how workflow innovation, such as the enhanced-PT pathway at Maine Medical Center, could help operationalize use of early mobilization. Click below for registration and more information about the session and speakers! https://lnkd.in/emWbmu5y

Exciting news! I’m proud to share my latest publication in JU Open Plus on "Patient Preferences for Surgical Treatments for Benign Prostatic Hyperplasia: A Discrete Choice Experiment", published, among others, together with my colleagues Vera Vennedey. This research emphasizes the critical role of #SharedDedcisionMaking under consideration of #PatientPreferenceInformation (PPI) to ensure treatment decisions align with what truly matters to the individual patients — their needs and expectations. Supporting and advancing patient preference research is something I feel deeply passionate about, and I’m always happy to connect for further projects in this field!

We are proud to share that the admedicum colleagues Vera Vennedey and Christian Hoenig authored, together with others, a new publication in the Journal JU Open Plus on Patient Preferences for Surgical Treatments for Benign Prostatic Hyperplasia: A Discrete Choice Experiment.    Read the full publication here: https://lnkd.in/dyj6Ysb8   This research highlights the importance of understanding what truly matters to patients when considering treatment options. By incorporating patient preference information (PPI), healthcare decisions become better aligned with patients' needs, values, and expectations – something we at admedicum are deeply committed to through our patient2decide solutions.   A big thank you to our dedicated team and co-authors for advancing patient-focused solutions in healthcare research!   #PatientEngagement #PatientPreferences #PatientExperience #SharedDecisionMaking  

Our informational symposium at #ASPN2024 starts at noon tomorrow and will emphasize the evidence behind Prospera™: ➡️ Learn about a robust clinical program that dates back to 2017 and includes multiple studies supporting therapy development, therapy validation, and a real-world study that validates the need for patient support beyond the implant. ➡️ Hear how proactive care is positively impacting patients, as demonstrated by real-world results from clinical practice. Don’t miss this opportunity to register: https://ow.ly/yf9M50Sv2Uu #BIOTRONIKNeuro #SpinalCordStimulation

AACR is fast approaching and we'd love to see you at the Tempus booths #1705 and #1611. Come talk to me and learn how we can intelligently map patient cohorts by overlaying your I/E criteria against our active subject database. We're building better, smarter clinical trials with true precision medicine. #AACR2024

The Alliance of Wound Care Stakeholders’ Wound Care Evidence Summit™ brought together payers, government agency policymakers, researchers, wound care medical specialty societies, patient and clinical associations, wound care clinics, and manufacturers to discuss wound care evidence and coverage issues while building actionable solutions. Dive into the key themes that arose during the summit, in this new editorial, published in "Advances in Wound Care". Clinical trial designer, biostatistician and Summit participant, Dr Marissa Carter, along with Winifred Hayes and Marcia Nusgart examine the quality, adequacy, and relevance of the existing chronic wound care research base and discuss gaps, associated problems, and implications for clinical trial design and execution as identified by Summit participants. #healthcarereimbursement #healthcarecoverage #evidencebasedmedicine #interprofessional #clinicaltrials #clinicalresearch #woundhealing https://lnkd.in/eNWSRmF2

From those living with IgG4-RD and their loved ones to physicians specializing in IgG4-RD, we encourage you to check out the new IgG4ward! Foundation Physician Network, which officially launches today! https://lnkd.in/egYQbvtW The Physician Network, which is comprised of physicians from 24 countries and territories across 6 continents, focusing on 12 different specialties and subspecialties, is a tool to help individuals more easily find a physician with expertise in IgG4-RD, hopefully reducing the time in receiving accurate diagnoses and appropriate care.    Dr. John Stone, IgG4ward! Founder shares:  "We hear over and over again of the difficulties our patients face in identifying doctors who are prepared to help them. Yet we see the medical community's keen interest in every aspect of IgG4-RD, which seems to grow every week in both the medical literature and at medical meetings. The IgG4ward! Foundation's Physician Network will help link patients to the committed physicians they need. I anticipate that the Network will continue to expand quickly, and we will post frequent updates."  If you're a physician or know a physician who may be interested in joining the Network, you can learn more here: https://lnkd.in/edaga22G #igg4rd #igg4relateddisease #raredisease #rarediseaseawareness  

Navigating the intricate landscape of clinical trials for ICU's and rare diseases is no small feat. Joab Williamson insightful article, "𝐓𝐫𝐢𝐚𝐥 𝐓𝐫𝐢𝐛𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬: 𝐍𝐚𝐯𝐢𝐠𝐚𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐱 𝐓𝐞𝐫𝐫𝐚𝐢𝐧 𝐨𝐟 𝐈𝐂𝐔 𝐚𝐧𝐝 𝐑𝐚𝐫𝐞 𝐃𝐢𝐬𝐞𝐚𝐬𝐞𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡," delves into the operational challenges these trials face, emphasizing the necessity for global collaboration, regulatory flexibility, and innovative trial designs. Discover how integrated research and patient-centered approaches can lead to equitable advancements in #medicaltreatments. By fostering a collaborative environment and embracing regulatory adaptability, we can overcome these challenges and pave the way for groundbreaking medical breakthroughs. Read more about the 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐭𝐨 𝐫𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐢𝐳𝐞 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥𝐬 and ensure better patient outcomes. Let's work together to create a future where every patient has access to the best possible care. 🔗 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐄-𝐛𝐨𝐨𝐤: https://lnkd.in/gTCs4cpe 🔗𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://lnkd.in/duKnzVCp #ClinicalTrials #ICU #RareDiseases #MedicalResearch #GlobalCollaboration #InnovativeDesign #RegulatoryFlexibility #PatientCenteredCare #MedicalAdvancements #ResearchInnovation #HealthcareEquity #ClinicalResearch #TrialDesign #PatientOutcomes #MedicalBreakthroughs

Celebrating Clinical Trials Day with Catalyst "To foster pioneering progress in the healthcare system, clinical discovery, and patient participation worldwide, we stand in need of a dedicated Clinical Trial Day." #ClinicalTrialsDay , #ClinicalResearch, #catalystclinicalresearch, #ConnectWithCatalyst Catalyst Clinical Research

On this World Patient Safety Day 2024, the World Health Organization emphasises the importance of accurate and timely diagnosis as a key driver for improving patient health and safety.   👉 Diagnostics serve as a navigation system for the care team to provide patients with the right care at the right time.   👉 The diagnostic process consists of several steps, each requiring great care and precision.   👉 Medical technology is a crucial aid for the care team throughout the entire cycle, including in-vitro diagnostic tests, medical imaging, and more.   👉 Making the right diagnosis is a team effort—among healthcare providers, between the healthcare team and the patient, and also between healthcare providers, policymakers, and industry to ensure timely access to valuable diagnostic tools.   We’d like to take this opportunity to once again highlight this interview with Julie HOTTON on in-vitro diagnostics (IVDs). As Head of Clinical Biology at Europa Ziekenhuizen, she clearly describes both the value and complexity of IVDs for patients, healthcare providers, and society.   You can read the interview on our website: - In French: https://lnkd.in/euFFzKTi - In Dutch: https://lnkd.in/eX66Usj4 💪 Let’s continue investing in diagnostics as an invaluable lever for patient safety and quality healthcare.   #medtechmatters #qualityofcare #patientsafety #WorldPatientSafetyDay #diagnostics